Search Tips

Clinical Proteomic Tumor Analysis Consortium Data

Alternate Titles(s): CPTAC

UID: 10109

Publisher(s): National Cancer Institute - Office of Cancer Clinical Proteomics Research

Description
The Clinical Proteomic Tumor Analysis Consortium (CPTAC) analyzes cancer biospecimens by mass spectrometry, characterizing and quantifying their constituent proteins, or proteome. Proteomic analysis for each CPTAC study is carried out independently by Proteomic Characterization Centers (PCCs) using a variety of protein fractionation techniques, instrumentation, and workflows. Mass spectrometry and related data files are organized into datasets by study, sub-proteome, and analysis site.
Subject(s)
OncoTree Cancer Type(s)
Invasive Breast Carcinoma
Breast
Renal Clear Cell Carcinoma
Colon Adenocarcinoma
Glioblastoma Multiforme
Liver
Lung Adenocarcinoma
Ovary/Fallopian Tube
Primary Brain Tumor
Rectal Adenocarcinoma
Skin
Esophagus/Stomach
Endometrial Carcinoma